Method for increasing expression of RNA-encoded proteins
KR20150121022A
Combination of vaccination and inhibition of the PD-1 pathway
KR20140142734A
Artificial nucleic acid molecules for improved protein or peptide expression
KR20140139101A
Artificial nucleic acid molecules comprising a 5'top utr
CA2866955A1
Artificial nucleic acid molecules
WO2013120498A1
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen
WO2013120497A1
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
WO2013120499A1
Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
WO2013120500A1
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
WO2013113325A1
Negatively charged nucleic acid comprising complexes for immunostimulation
WO2013113326A1
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
CN103025876A
Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
WO2012116715A1
Vaccination in newborns and infants
WO2012116714A1
Vaccination in elderly patients
WO2012113413A1
Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
